ConductScience.org, home

Library / Trials

Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

NCT03893032, Phase 2, Unknown, United States Army Aeromedical Research Laboratory

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleEnhancing Operational Performance in Healthy Rested Soldiers With Pharmacological StimulantsClinicalTrials.gov
NCT numberNCT03893032ClinicalTrials.gov
StatusUnknownClinicalTrials.gov
PhasesPhase 2ClinicalTrials.gov
Enrollment80 participants, estimatedClinicalTrials.gov
Lead sponsorUnited States Army Aeromedical Research LaboratoryClinicalTrials.gov
ConditionsCognitionClinicalTrials.gov
InterventionsModafinil 200mg, mixed amphetamine salts, PlaceboClinicalTrials.gov
First posted2019-03-27ClinicalTrials.gov
Last updated2019-07-31ClinicalTrials.gov

Registered outcomes 8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
Primarychange from baseline in working memory performance2-hours post-dosingDigit span taskClinicalTrials.gov
Primarychange from baseline in selective attention performance2-hours post-dosingStroop testClinicalTrials.gov
Primarychange from baseline in sustained attention performance2-hours post-dosingRapid Visual Information Processing TaskClinicalTrials.gov
Primarychange from baseline in executive function performance2-hours post-dosingDigit symbol substitution taskClinicalTrials.gov
Primarychange from baseline in marksmanship performance2-hours post-dosingnumber of targets acquired on marksmanship trainerClinicalTrials.gov
Secondarychange from baseline in impulsivity2-hours post-dosingStop signal task - response inhibitionClinicalTrials.gov
Secondarychange from baseline in impulsivity2-hours post-dosingContinuous Performance test - rapid response initiationClinicalTrials.gov
Secondarychange from baseline in risk-taking behavior2-hours post-dosing
Evaluation of Risks Scale; measures individual variability in risk assessment; three scores are produced ("need for control", "self-confidence", "risk/thrill seeking"), all scores range from 0 to 100 with higher scores indicating a higher degree of the construct (e.g., higher risk/thrill seeking scores indicate a greater degree of risk/thrill seeking)
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 6

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Digit Span TestPrimary outcomeConductCognition
Rapid Visual Information ProcessingPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Symbol CodingPrimary outcomeConductCognition
Continuous Performance TestSecondary outcomeConductCognition
Stop-Signal TaskSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)